Abstract
The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Current Topics in Medicinal Chemistry
Title: Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
Volume: 11 Issue: 21
Author(s): Adoracion G. Quiroga
Affiliation:
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Abstract: The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Export Options
About this article
Cite this article as:
G. Quiroga Adoracion, Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs, Current Topics in Medicinal Chemistry 2011; 11 (21) . https://dx.doi.org/10.2174/156802611798040723
DOI https://dx.doi.org/10.2174/156802611798040723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Current Gene Therapy Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Current Drug Therapy Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets Protective Effects of Incretin Against Age-Related Diseases
Current Drug Delivery HIV-1 Vpr: Enhancing Sensitivity of Tumors to Apoptosis
Current Drug Delivery The “Invisible Proteome”: How to Capture the Low-Abundance Proteins Via Combinatorial Ligand Libraries
Current Proteomics Recent Patents, Formulation and Characterization of Nanoliposomes
Recent Patents on Drug Delivery & Formulation Isomers of 4-[<sup>18</sup>F]fluoro-proline: Radiosynthesis, Biological Evaluation and Results in Humans Using PET
Current Radiopharmaceuticals Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges
Current Drug Targets Comparative Binding Analysis of Monoclonal Antibodies Against Native and Mutant Type in ErbB2 Receptor: A Theoretical Modeling Approach
Current Pharmaceutical Biotechnology Transcriptional Regulation of Inflammatory Genes Associated with Severe Asthma
Current Pharmaceutical Design Withdrawal Notice: Emerging Biomarkers and Contributing Factors of Prostate Cancer
Current Cancer Therapy Reviews Targeted Therapies in Gynecologic Cancers
Current Cancer Drug Targets Patents Related to Cancer Stem Cell Research
Recent Patents on DNA & Gene Sequences Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine